Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival

Translational Research

Volumn 156, Issue 1, 2010, Pages 45-52

  Ding, Lianshu ^a   Sun, Xiaoyang ^a   You, Yongping ^a   Liu, Ning ^a   Fu, Zhen ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE;

ADULT; ARTICLE; BRAIN BIOPSY; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME PHOSPHORYLATION; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SURVIVAL RATE; SYSTEMIC THERAPY; WORLD HEALTH ORGANIZATION;

EID: 77953590163     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.05.001     Document Type: Article

References (31)

1. Kleihues P., and Sobin L.H. World Health Organization classification of tumors. Cancer 88 (2000) 2887
2. Noble M., and Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci 27 (2004) 148-154
3. Uematsu M., Ohsawa I., Aokage T., et al. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol 72 (2005) 231-238
4. Schaller M.D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 1540 (2001) 1-21
5. Shibata K., Kikkawa F., Nawa A., et al. Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronection in ovarian cancer cells. Cancer Res 58 (1998) 900-903
6. Sein T.T., Thant A.A., Hiraiwa Y., et al. A role for FAK in the Concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9. Oncogene 19 (2000) 5539-5542
7. Parsons J.T. Focal Adhesion Kinase: the first ten years. J Cell Sci 116 (2003) 1409-1416
8. Schlaepfer D.D., Hauck C.R., and Sieg D.J. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71 (1999) 435-478
9. Owens L.V., Xu L.H., Craven R.J., et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumor. Cancer Res 55 (1995) 2752-2755
10. Kamo N., Naomoto Y., Shirakawa Y., et al. Involvement of focal adhesion kinase in the progression and prognosis of gastrointestinal stromal tumors. Hum Path 40 (2009) 1643-1649
11. Tremblay L., Hauk W., Aprikian A.G., Begin L.R., Chapdelaine A., and Chevalier S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int J Cancer 68 (1996) 164-171
12. Owens L.V., Xu L.H., Dent G.A., et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 3 (1996) 100-105
13. Judson P.L., He X.H., Cance W.G., and Le L.V. Overexpression of focal adhesion kinase, a protein kinase, in ovarian carcinoma. Cancer 86 (1999) 1551-1556
14. Kornberg L.J. Focal adhesion kinase expression in oral cancers. Head Neck 20 (1998) 634-639
15. Zagzag D., Friedlander D.F., Margolis B., et al. Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg 33 (2000) 49-55
16. Lipinski C.A., Tran N.L., Bay C., et al. Differential role of prolinerich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation. Mol Cancer Res 1 (2003) 323-332
17. Aronsohn M.S., Brown H.M., Hauptman G., and Kornberg L.J. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope 113 (2003) 1944-1948
18. Chakravarti A., Noll E., and Black P.M. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20 (2002) 1063-1068
19. Kajiwara Y., Yamasaki F., and Hama S. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 97 (2003) 1077-1083
20. Caldas H., Jiang Y., and Holloway M.P. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24 (2005) 1994-2007
21. Kuan C.T., Wakiya K., Dowell J.M., et al. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin Cancer Res 12 (2006) 1970-1982
22. Ali-Osman F., Brunner J.M., Kutluk T.M., and Hess K. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin Cancer Res 3 (1997) 2253-2261
23. Rodriguez-Fernandez J.L., and Rozengurt E. Bombesin, Vasopressin, lysophosphatidic acid, and sphingosylphorylcholine induce focal adhesion kinase activation in intact Swiss 3T3 cells. J Biol Chem 273 (1998) 19321-19328
24. Schlaepfer D.D., and Hunter T. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on Focal Adhesion Kinase by Src-family protein-tyrosine kinases. Mol Cell Biol 16 (1996) 5623-5633
25. Kornberg L.J. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 20 (1998) 745-752
26. Schlaepfer D.D., and Mitra S.K. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14 (2004) 92-101
27. Jones G., Machado Jr. J., Tolnay M., and Merlo A. PTENindependent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). Cancer Res 61 (2001) 5688-5691
28. Hauck C.R., Sieg D.J., Hsia D.A., et al. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res 61 (2001) 7079-7090
29. Gutenberg A., Bruck W., Buchfelder M., and Ludwig H.C. Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol 108 (2004) 224-230
30. Shi Q., Hjelmeland A., Keir S., et al. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol Carcinog 46 (2007) 488-496
31. Hayashi A., Aishima S., Inoue T., et al. Decreased expression of focal adhesion kinase is associated with a poor prognosis in extrahepatic bile duct carcinoma. Hum Pathol (2010) [Epub ahead of print]